Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, REF: PRD-07400
FDA Device Recall #Z-0694-2025 — Class II — November 8, 2024
Recall Summary
| Recall Number | Z-0694-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 8, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hologic, Inc. |
| Location | San Diego, CA |
| Product Type | Devices |
| Quantity | 3 |
Product Description
Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, REF: PRD-07400
Reason for Recall
SARS-CoV-2/Flu A/B/RSV Assay Kit may erroneously produce SARS-CoV-2 false positive results.
Distribution Pattern
US: AK
Lot / Code Information
UDI-DI: 15420045515352 Kit lot 892307, Expiration: May 15, 2025. Cartridge Lot 890494
Other Recalls from Hologic, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1095-2025 | Class II | The Rapid fFN Specimen Collection Tube (PN: 715... | Jan 8, 2025 |
| Z-0907-2025 | Class II | Panther Fusion GBS Assay REF PRD-04484 Kit cont... | Dec 13, 2024 |
| Z-0782-2024 | Class II | PANTHER FUSION System REF 9121010000 The P... | Dec 15, 2023 |
| Z-1371-2024 | Class II | Aptima CMV Quant Assay, Reference numbers: AW-2... | Sep 14, 2023 |
| Z-1144-2023 | Class II | Hologic 3Dimensions/Selenia Dimensions Models... | Jan 16, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.